Nationwide Class For Vioxx Suit Rejected

Law360, New York (September 6, 2007, 12:00 AM EDT) -- Handing Merck & Co. a victory, the New Jersey Supreme Court on Thursday reversed a lower court ruling that certified a nationwide class of Vioxx consumers attempting to get back the money they spent on the drug.

The supreme court cited two reasons for rejecting the certification of a nationwide class of insurance companies and other third-parties. The claims of the third-party payors involved different questions of fact or law, and a class action in this case would not be superior to other available methods of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.